E. Saridogan et al., ANGIOTENSIN-II RECEPTORS AND ANGIOTENSIN-II STIMULATION OF CILIARY ACTIVITY IN HUMAN FALLOPIAN-TUBE, The Journal of clinical endocrinology and metabolism, 81(7), 1996, pp. 2719-2725
Using an antibody (6313/G2) directed against a specific sequence in th
e extracellular domain of the type 1 angiotensin II receptor (AT(1)),
we demonstrated the presence of angiotensin II (AII) receptors in huma
n fallopian tube. Immunoperoxidase staining for AT(1) receptor showed
positive staining in the epithelium of the tubal mucosa. The intensity
of staining varied depending upon the hormonal status at the time of
salpingectomy, being strongest in the proliferative phase of the ovari
an cycle and weakest after menopause. Ligand binding assay confirmed t
hat the AII receptor concentration was highest in the mucosa of fallop
ian tubes from premenopausal women. Mucosa from the ampullary segment
had higher concentrations of AII receptor than the fimbrial and isthmi
c segments in both premenopausal and postmenopausal women. Displacemen
t studies using specific AII receptor subtype antagonists showed that
approximately 60% of the total activity could be displaced by CGP42112
B (type 2 specific) and 40% by losartan (AT(1) specific). Immunoblotti
ng confirmed that the antibody detected a protein of approximately 60
kDa. Functional studies showed that AII had a stimulatory action on tu
bal ciliary beat frequency, but had no significant effect on myosalpin
geal activity. This effect was achieved at nanomolar concentrations of
AII; further increases in the AII concentration were without addition
al effect. The stimulatory effect of AII was inhibited by the specific
AT(1) antagonist losartan, whereas the type 2 antagonist, CGP42112B,
had no effect. The data demonstrate that AII may play an important rol
e in ovum transport and fertility.